书信:莱瓦米索尔 (Levamisole) 是一种

Same author

Vascular Protection by Ketanserin, a 5-HT(2) Serotonergic Receptor Antagonist?

Platelets·2010

Same author

Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.

Journal of cardiovascular pharmacology·1991

Same author

Ketanserin: a novel cardiovascular drug.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1990

Same author

[Clinical profile of a new antihypertensive agents. Ketanserin].

Revue medicale de Liege·1988

Same author

Ketanserin and QTc prolongation.

European heart journal·1987

Same author

Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1986

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

相关实验视频

书信:莱瓦米索尔 (Levamisole) 是一种

相关概念视频

Vascular Protection by Ketanserin, a 5-HT(2) Serotonergic Receptor Antagonist?

Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.

Ketanserin: a novel cardiovascular drug.

[Clinical profile of a new antihypertensive agents. Ketanserin].

Ketanserin and QTc prolongation.

Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

相关实验视频

书信:莱瓦米索尔 (Levamisole) 是一种

相关概念视频

相关文章

Vascular Protection by Ketanserin, a 5-HT(2) Serotonergic Receptor Antagonist?

Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.

Ketanserin: a novel cardiovascular drug.

[Clinical profile of a new antihypertensive agents. Ketanserin].

Ketanserin and QTc prolongation.

Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.